{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T09:20:13Z","timestamp":1788081613934,"version":"build-2784847793"},"reference-count":81,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpagonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric and Adolescent Gynecology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.jpag.2010.08.005","type":"journal-article","created":{"date-parts":[[2010,10,11]],"date-time":"2010-10-11T10:48:31Z","timestamp":1286794111000},"page":"S3-S10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"S","title":["von Willebrand Disease in the Pediatric and Adolescent Population"],"prefix":"10.1016","volume":"23","author":[{"given":"Sameh","family":"Mikhail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kouides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpag.2010.08.005_bib1","first-page":"87","article-title":"Hereditar pseudohemofili","volume":"67","author":"Von Willebrand","year":"1926","journal-title":"Fin Lakarsallsk Handl"},{"key":"10.1016\/j.jpag.2010.08.005_bib2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.pcl.2008.01.008","article-title":"Von Willebrand disease","volume":"55","author":"Robertson","year":"2008","journal-title":"Pediatr Clin North Am"},{"issue":"9101","key":"10.1016\/j.jpag.2010.08.005_bib3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)08248-2","article-title":"Frequency of inherited bleeding disorders in women with menorrhagia","volume":"351","author":"Kadir","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jpag.2010.08.005_bib4","first-page":"630","article-title":"von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagia","volume":"97","author":"Dilley","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jpag.2010.08.005_bib5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00001721-200203000-00003","article-title":"von Willebrand's disease: an important cause of dysfunctional uterine bleeding","volume":"13","author":"Woo","year":"2002","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jpag.2010.08.005_bib6","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/(SICI)1096-8652(199612)53:4<234::AID-AJH4>3.0.CO;2-Z","article-title":"On the value of menorrhagia as a predictor for coagulation disorders","volume":"53","author":"Edlund","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jpag.2010.08.005_bib7","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1538-7836.2003.00061.x","article-title":"Platelet functional defects in women with unexplained menorrhagia","volume":"1","author":"Philipp","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jpag.2010.08.005_bib8","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1365-2516.2000.00447.x","article-title":"Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey","volume":"6","author":"Kouides","year":"2000","journal-title":"Haemophilia"},{"key":"10.1016\/j.jpag.2010.08.005_bib9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1365-2516.1999.00342.x","article-title":"von Willebrand disease and bleeding in women","volume":"5","author":"Ragni","year":"1999","journal-title":"Haemophilia"},{"key":"10.1016\/j.jpag.2010.08.005_bib10","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1046\/j.1365-2516.2003.00756.x","article-title":"Medical, reproductive and psychosocial experiences of women diagnosed with von Willebrand's disease receiving care in haemophilia treatment centres: a case-control study","volume":"9","author":"Kirtava","year":"2003","journal-title":"Haemophilia"},{"key":"10.1016\/j.jpag.2010.08.005_bib11","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand's disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.jpag.2010.08.005_bib12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1538-7836.2009.03661.x","article-title":"The prevalence of symptomatic von Willebrand disease in primary care practice","volume":"8","author":"Bowman","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jpag.2010.08.005_bib13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/pbc.22429","article-title":"A prospective evaluation of the prevalence of symptomatic von Willebrand disease (VWD) in a pediatric primary care population","volume":"55","author":"Bowman","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpag.2010.08.005_bib14","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1067\/mpd.2001.113042","article-title":"Bleeding disorders: A common cause of menorrhagia in adolescents","volume":"138","author":"Bevan","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpag.2010.08.005_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0002-9378(81)90009-0","article-title":"Acute adolescent menorrhagia","volume":"139","author":"Claessens","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jpag.2010.08.005_bib16","first-page":"761","article-title":"Dysfunctional uterine bleeding in adolescents","volume":"39","author":"Falcone","year":"1994","journal-title":"J Reprod Med"},{"key":"10.1016\/j.jpag.2010.08.005_bib17","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1479-828X.2005.00470.x","article-title":"Bleeding disorders in teenagers presenting with menorrhagia","volume":"45","author":"Jayasinghe","year":"2005","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.jpag.2010.08.005_bib18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1515\/IJAMH.2004.16.2.183","article-title":"Coagulation disorders as the cause of menorrhagia in adolescents","volume":"16","author":"Kanbur","year":"2004","journal-title":"Int J Adolesc Med Health"},{"key":"10.1016\/j.jpag.2010.08.005_bib19","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1365-2516.2007.01496.x","article-title":"The prevalence of disorders of haemostasis in adolescents with menorrhagia referred to a haemophilia treatment centre","volume":"13","author":"Mikhail","year":"2007","journal-title":"Haemophilia"},{"key":"10.1016\/j.jpag.2010.08.005_bib20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s004040100192","article-title":"Hematological abnormalities in adolescent menorrhagia","volume":"266","author":"Oral","year":"2002","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jpag.2010.08.005_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/01.AOG.0000148889.15061.fb","article-title":"Age and the prevalence of bleeding disorders in women with menorrhagia","volume":"105","author":"Philipp","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jpag.2010.08.005_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1083-3188(98)70101-9","article-title":"Menorrhagia in adolescents requiring hospitalization","volume":"11","author":"Smith","year":"1998","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.jpag.2010.08.005_bib23","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1538-7836.2006.01847.x","article-title":"A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)","volume":"4","author":"Tosetto","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jpag.2010.08.005_bib24","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/j.1538-7836.2005.01663.x","article-title":"The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study","volume":"3","author":"Rodeghiero","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jpag.2010.08.005_bib25","first-page":"420","article-title":"Clinical features and laboratory patterns in a cohort of consecutive Argentinian patients with von Willebrand's disease","volume":"86","author":"Woods","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.jpag.2010.08.005_bib26","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-0038-1647493","article-title":"Bleeding symptoms in carriers of hemophilia A and B","volume":"59","author":"Mauser Bunschoten","year":"1988","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jpag.2010.08.005_bib27","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/archinte.1995.00430130095010","article-title":"Usefulness of patient interview in bleeding disorders","volume":"155","author":"Sramek","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jpag.2010.08.005_bib28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1055\/s-0038-1647491","article-title":"Bleeding\/bruising symptomatology in children with and without bleeding disorders","volume":"65","author":"Nosek-Cenkowska","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jpag.2010.08.005_bib29","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1111\/j.1538-7836.2008.03182.x","article-title":"Generation and validation of the Condensed MCMDM-1VWD Bleeding Questionnaire for von Willebrand disease","volume":"6","author":"Bowman","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jpag.2010.08.005_bib30","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/j.1538-7836.2009.03499.x","article-title":"Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire","volume":"7","author":"Bowman","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jpag.2010.08.005_bib31","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/j.1538-7836.2010.03796.x","article-title":"Quantitation of bleeding symptoms in children with von Willebrand disease: use of a standardized pediatric bleeding questionnaire","volume":"8","author":"Biss","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jpag.2010.08.005_bib32","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1182\/blood.V56.4.712.712","article-title":"Serial studies in von Willebrand's disease: variability versus \"variants","volume":"56","author":"Abildgaard","year":"1980","journal-title":"Blood"},{"key":"10.1016\/j.jpag.2010.08.005_bib33","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.jpag.2010.08.005_bib34","doi-asserted-by":"crossref","first-page":"12.e1","DOI":"10.1016\/j.ajog.2009.04.024","article-title":"Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel","volume":"201","author":"James","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jpag.2010.08.005_bib35","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1055\/s-0037-1614855","article-title":"Variations in coagulation factors in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptive","volume":"82","author":"Kadir","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jpag.2010.08.005_bib36","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJM198005083021923","article-title":"Variations in factor VIII during the menstrual cycle in normal women","volume":"302","author":"Mandalaki","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpag.2010.08.005_bib37","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1055\/s-0037-1613140","article-title":"Changes in von Willebrand factor and factor VIII levels during the menstrual cycle","volume":"87","author":"Miller","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jpag.2010.08.005_bib38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/01.mbc.0000198990.16598.85","article-title":"Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease","volume":"17","author":"Bohm","year":"2006","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jpag.2010.08.005_bib39","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1365-2516.2003.00718_1.x","article-title":"Misdiagnosis by milk box","volume":"9","author":"Lipton","year":"2003","journal-title":"Haemophilia"},{"key":"10.1016\/j.jpag.2010.08.005_bib40","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jpag.2010.08.005_bib41","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1538-7836.2006.01860.x","article-title":"Genetic linkage and association analysis in type 1 von Willebrand disease: results from the Canadian type 1 VWD study","volume":"4","author":"James","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jpag.2010.08.005_bib42","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1538-7836.2006.01823.x","article-title":"Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD","volume":"4","author":"Eikenboom","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jpag.2010.08.005_bib43","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1160\/TH07-06-0419","article-title":"Distribution of von Willebrand factor levels in young women with and without bleeding symptoms: influence of ABO blood group and promoter haplotypes","volume":"99","author":"Lethagen","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jpag.2010.08.005_bib44","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jpag.2010.08.005_bib45","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jpeds.2010.03.009","article-title":"Cost-utility analysis of von Willebrand disease screening in adolescents with menorrhagia","volume":"157","author":"Sidonio","year":"2010","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpag.2010.08.005_bib46","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1182\/blood-2009-01-153296","article-title":"How I treat von Willebrand disease","volume":"114","author":"Rodeghiero","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jpag.2010.08.005_bib47","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1080\/07853890701513738","article-title":"Management of inherited von Willebrand disease in 2007","volume":"39","author":"Federici","year":"2007","journal-title":"Ann Med"},{"key":"10.1016\/j.jpag.2010.08.005_bib48","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/ajh.20940","article-title":"The use of desmopressin as a hemostatic agent: a concise review","volume":"82","author":"Franchini","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jpag.2010.08.005_bib49","first-page":"272","article-title":"Tranexamic acid in the control of spontaneous bleeding in severe haemophilia","volume":"30","author":"Rainsford","year":"1973","journal-title":"Thromb Diath Haemorrh"},{"key":"10.1016\/j.jpag.2010.08.005_bib50","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2165\/00002018-200831040-00001","article-title":"A benefit-risk review of systemic haemostatic agents: part 2: in excessive or heavy menstrual bleeding","volume":"31","author":"Fraser","year":"2008","journal-title":"Drug Saf"},{"key":"10.1016\/j.jpag.2010.08.005_bib51","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1055\/s-0038-1650645","article-title":"Prospective multicenter study on subcutaneous concentrated desmopressin for home treatment of patients with von Willebrand disease and mild or moderate hemophilia A","volume":"76","author":"Rodeghiero","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jpag.2010.08.005_bib52","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/0310057X0002800214","article-title":"Severe hyponatraemia secondary to desmopressin therapy in von Willebrand's disease","volume":"28","author":"Bertholini","year":"2000","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.jpag.2010.08.005_bib53","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2133.1993.tb15161.x","article-title":"Tranexamic acid (Cyklokapron)-induced fixed-drug eruption","volume":"128","author":"Kavanagh","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jpag.2010.08.005_bib54","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.annfar.2004.04.012","article-title":"A case of anaphylactic shock with tranexamique acid (Exacyl)","volume":"23","author":"Lucas-Polomeni","year":"2004","journal-title":"Ann Fr Anesth Reanim"},{"issue":"8664","key":"10.1016\/j.jpag.2010.08.005_bib55","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(89)90915-X","article-title":"Desmopressin and thrombosis","volume":"2","author":"Mannucci","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.jpag.2010.08.005_bib56","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ajh.2830280115","article-title":"Thrombosis following desmopressin for uremic bleeding","volume":"28","author":"Byrnes","year":"1988","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jpag.2010.08.005_bib57","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1055\/s-0037-1616258","article-title":"Cerebral arterial thrombosis in a young woman following vasopressin for von Willebrand's disease","volume":"93","author":"Grainge","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jpag.2010.08.005_bib58","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1742-1241.1989.tb08809.x","article-title":"Massive pulmonary thromboembolism after tranexamic acid antifibrinolytic therapy","volume":"43","author":"Woo","year":"1989","journal-title":"Br J Clin Pract"},{"key":"10.1016\/j.jpag.2010.08.005_bib59","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1034\/j.1600-0609.2002.01607.x","article-title":"Pulmonary embolism associated with tranexamic acid in severe acquired haemophilia","volume":"68","author":"Taparia","year":"2002","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jpag.2010.08.005_bib60","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1055\/s-0038-1649475","article-title":"Treatment with tranexamic acid during pregnancy, and the risk of thrombo-embolic complications","volume":"70","author":"Lindoff","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jpag.2010.08.005_bib61","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1055\/s-0037-1616122","article-title":"No increased risk of venous thrombosis in women taking tranexamic acid","volume":"86","author":"Berntorp","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jpag.2010.08.005_bib62","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1046\/j.1365-2516.2002.00678.x","article-title":"DDAVP nasal spray for treatment of menorrhagia in women with inherited bleeding disorders: a randomized placebo-controlled crossover study","volume":"8","author":"Kadir","year":"2002","journal-title":"Haemophilia"},{"key":"10.1016\/j.jpag.2010.08.005_bib63","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1365-2516.2001.00500.x","article-title":"High-dose DDAVP intranasal spray (Stimate) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A","volume":"7","author":"Leissinger","year":"2001","journal-title":"Haemophilia"},{"key":"10.1016\/j.jpag.2010.08.005_bib64","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1182\/blood.V90.7.2515","article-title":"Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years","volume":"90","author":"Mannucci","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jpag.2010.08.005_bib65","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2141.1981.tb02789.x","article-title":"Response of factor VIII\/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease","volume":"47","author":"Mannucci","year":"1981","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jpag.2010.08.005_bib66","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1182\/blood.V74.6.1997.1997","article-title":"Consistency of responses to repeated DDAVP infusions in patients with von Willebrand's disease and hemophilia A","volume":"74","author":"Rodeghiero","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.jpag.2010.08.005_bib67","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2516.2008.01655.x","article-title":"Laboratory response to intranasal desmopressin in women with menorrhagia and platelet dysfunction","volume":"14","author":"Rose","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.jpag.2010.08.005_bib68","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-2516.2000.00367.x","article-title":"Adverse events during use of intranasal desmopressin acetate for haemophilia A and von Willebrand disease: a case report and review of 40 patients","volume":"6","author":"Dunn","year":"2000","journal-title":"Haemophilia"},{"key":"10.1016\/j.jpag.2010.08.005_bib69","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/01.mph.0000173175.95152.95","article-title":"Oral contraceptives and DDAVP nasal spray: patterns of use in managing vWD-associated menorrhagia: a single-institution study","volume":"27","author":"Amesse","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jpag.2010.08.005_bib70","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJM199807233390407","article-title":"Hemostatic drugs","volume":"339","author":"Mannucci","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpag.2010.08.005_bib71","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-2141.2009.07610.x","article-title":"Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid","volume":"145","author":"Kouides","year":"2009","journal-title":"Br J Haematol"},{"issue":"1342","key":"10.1016\/j.jpag.2010.08.005_bib72","first-page":"54","article-title":"Tranexamic acid (Lysteda) for treatment of menorrhagia","volume":"52","year":"2010","journal-title":"Med Lett Drugs Ther"},{"key":"10.1016\/j.jpag.2010.08.005_bib73","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/03009738909178559","article-title":"Coagulation and fibrinolysis during the normal menstrual cycle","volume":"942","author":"Siegbahn","year":"1989","journal-title":"Ups J Med Sci"},{"key":"10.1016\/j.jpag.2010.08.005_bib74","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1055\/s-0038-1649813","article-title":"The reproductive health of women with von Willebrand Disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH","volume":"74","author":"Foster","year":"1995","journal-title":"Thromb Haemost"},{"issue":"16 Suppl 1","key":"10.1016\/j.jpag.2010.08.005_bib75","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/01.mbc.0000167659.23262.18","article-title":"Long-term prophylaxis in von Willebrand disease","author":"Berntorp","year":"2005","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jpag.2010.08.005_bib76","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1111\/j.1538-7836.2006.02179.x","article-title":"von Willebrand Disease Prophylaxis Network Steering Committee. The von Willebrand disease prophylaxis network: exploring a treatment concept","volume":"4","author":"Berntorp","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jpag.2010.08.005_bib77","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1111\/j.1538-7836.2005.01435.x","article-title":"Pharmacokinetic studies on Wilfactin, a von Willebrand factor concentrate with a low factor VIII content treated with three virus-inactivation\/removal methods","volume":"3","author":"Goudemand","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jpag.2010.08.005_bib78","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1538-7836.2007.02562.x","article-title":"Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin): a prospective study of 50 patients","volume":"5","author":"Borel-Derlon","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jpag.2010.08.005_bib79","first-page":"117","article-title":"Italian Association of Hemophilia Centers: Evidence-based recommendations on the treatment of von Willebrand disease in Italy","volume":"7","author":"Mannucci","year":"2009","journal-title":"Blood Transfus"},{"key":"10.1016\/j.jpag.2010.08.005_bib80","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ajh.2830250106","article-title":"Correction of the bleeding time in treated patients with severe von Willebrand disease is not solely dependent on the normal multimeric structure of plasma von Willebrand factor","volume":"25","author":"Mannucci","year":"1987","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jpag.2010.08.005_bib81","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood.V77.9.1901.1901","article-title":"Hemostatic effect of normal platelet transfusion in severe von Willebrand disease patients","volume":"77","author":"Castillo","year":"1991","journal-title":"Blood"}],"container-title":["Journal of Pediatric and Adolescent Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083318810002494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083318810002494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:37:47Z","timestamp":1761053867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083318810002494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":81,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S1083318810002494"],"URL":"https:\/\/doi.org\/10.1016\/j.jpag.2010.08.005","relation":{},"ISSN":["1083-3188"],"issn-type":[{"value":"1083-3188","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"von Willebrand Disease in the Pediatric and Adolescent Population","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric and Adolescent Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpag.2010.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}